Clinical features of adult moyamoya disease with special reference to the diagnosis
Jeong Eun Kim1, Kang Min Kim, Jeong Gyun Kim
1Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
Abstract:
Fifteen years of experience with adult moyamoya disease (MMD) in a single department were analyzed to describe the clinical features and to clarify the existence of the disease entity of adult MMD with special reference to its diagnosis. This study included 348 patients treated between 1996 and 2010. Male to female ratio was 128 to 220 with mean age of 39 years. The presence of neurological symptoms and signs during childhood and mean Suzuki stage according to the age were evaluated. Adult MMD was differentiated from other diseases, such as vasculitis, by comparing the laboratory data including common markers and specific markers for such diseases between 22 adult MMD and 21 atherosclerotic disease (ASD) patients. Conventional angiographic data were analyzed to detect progression in 52 unilateral adult MMD patients over a mean follow-up duration of 4.8 years. Only one of 128 patients (0.8%) aged over 40 years showed childhood symptoms and signs. The distribution of the mean Suzuki stage between patients aged 40 years and under and over 40 years was similar. Laboratory tests differentiating the other diseases with the same phenotype with MMD revealed no difference between adult MMD and ASD. The progression of unilateral MMD to bilateral MMD occurred in 6 of 52 patients (11.5%). Adult MMD is not a syndrome, but a distinct disease entity with significant progression of unilateral MMD to bilateral MMD. Diagnostic and therapeutic strategies should be different from pediatric cases when considering adult MMD.
Insights
Adult moyamoya disease (MMD) is a distinct entity, not a syndrome. Studies show progression from unilateral to bilateral MMD, necessitating different diagnostic and treatment strategies compared to pediatric cases.
Area of Science:
- Neurology
- Vascular Neurology
- Neuroimaging
Background:
- Moyamoya disease (MMD) is a rare cerebrovascular disorder.
- Distinguishing adult MMD from other conditions with similar presentations is crucial for accurate diagnosis and management.
Purpose of the Study:
- To analyze clinical features of adult MMD over 15 years.
- To establish adult MMD as a distinct disease entity.
- To evaluate diagnostic criteria and disease progression.
Main Methods:
- Retrospective analysis of 348 adult MMD patients (1996-2010).
- Comparison of laboratory data between adult MMD and atherosclerotic disease (ASD) patients.
- Angiographic assessment of disease progression in unilateral MMD.
Main Results:
- Adult MMD patients rarely present with childhood symptoms (0.8% over 40).
- Laboratory tests did not differentiate adult MMD from ASD.
- 11.5% of unilateral MMD cases progressed to bilateral MMD.
Conclusions:
- Adult MMD is a distinct disease entity, not a syndrome.
- Significant progression from unilateral to bilateral MMD occurs.
- Diagnostic and therapeutic approaches for adult MMD should differ from pediatric cases.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Coronary Artery Disease III: Clinical Manifestations
